eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 11/08/2011
PIL Remicade 100mg powder for concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 24/06/2011 and displayed until 11/08/2011
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to date of revision
  • Change to dosage and administration
Updated on 10/05/2011 and displayed until 24/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
Updated on 04/03/2011 and displayed until 10/05/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Company name change or merger
Updated on 17/02/2011 and displayed until 04/03/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Extra statutory information
Updated on 05/01/2011 and displayed until 17/02/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 13/05/2010 and displayed until 05/01/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to MA holder contact details
Updated on 26/01/2010 and displayed until 13/05/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 07/07/2009 and displayed until 26/01/2010
Reasons for adding or updating:
  • Change to Further Information section
Updated on 24/08/2007 and displayed until 07/07/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 21/08/2007 and displayed until 24/08/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 04/09/2006 and displayed until 21/08/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 21/12/2005 and displayed until 04/09/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 12/08/2005 and displayed until 21/12/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 11/02/2002 and displayed until 12/08/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  infliximab